High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients--authors' response
Author(s) -
D. Rey,
Bruno Hoën,
P. Chavanet,
MariePaule Schmitt,
Guillaume Hoizey,
P. Meyer,
Gilles Peytavin,
Bruno Spire,
Clotilde Allavena,
Myriam Diemer,
T. May,
J.L. Schmit,
Michel Duong,
Vincent Cálvez,
Jean-Marie Lang
Publication year - 2009
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp064
Subject(s) - nevirapine , lamivudine , tenofovir , medicine , virology , human immunodeficiency virus (hiv) , emtricitabine , viral load , antiretroviral therapy , virus , hepatitis b virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom